Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination
Xiaoyu Zhao, Tianyi Qiu, Xiner Huang, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3
Yuanchen Liu, Xiaoyu Zhao, Jialu Shi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection
Lei Yu, Yajie Wang, Yuanchen Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus
Richard Adeleke, Julie Sahler, Annette Choi, et al.
Science Advances (2025) Vol. 11, Iss. 5
Closed Access
Thymic stromal lymphopoietin improves protective immunity of the SARS-CoV-2 subunit vaccine by inducing dendritic cell-dependent germinal center response
Hao Hu, Ying Zhang, Housheng Zheng, et al.
Journal of Virology (2025)
Closed Access
Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection
Yu Lei, Yajie Wang, Yuanchen Liu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Epistasis between N-terminal and receptor-binding domains drives cell entry in a bat coronavirus spike
Alexandra L. Tse, Cory M. Acreman, Inna Ricardo-Lax, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Considerations for the development of monoclonal antibodies to address new viral variants in COVID-19
Arturo Casadevall, Scott A. McConnell, Daniele Focosi
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 8, pp. 787-797
Closed Access | Times Cited: 3
Structural review of SARS-CoV-2 antiviral targets
Wen Cui, Yinkai Duan, Gao Yan, et al.
Structure (2024) Vol. 32, Iss. 9, pp. 1301-1321
Closed Access | Times Cited: 2
COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort
Michael L. Mallory, Jennifer E. Munt, Tara M. Narowski, et al.
Science Advances (2024) Vol. 10, Iss. 24
Open Access | Times Cited: 1
Bispecific Antibodies Provide Broad Neutralization of Emerging Beta-Coronaviruses by Targeting ACE2 and Viral Spikes
Minghui Li, Chaoyue Zhao, Jialu Shi, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Distinct pathways for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses
Alexandra L. Tse, Cory M. Acreman, Inna Ricardo-Lax, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012704-e1012704
Open Access | Times Cited: 1
Vascular endothelial growth factor receptor 2 as a potential host target for the inhibition of enterovirus replication
Xiaoyu Zhao, Rui Qiao, Meng Hao, et al.
Journal of Virology (2024) Vol. 98, Iss. 10
Open Access
Page 1

Scroll to top